Your browser doesn't support javascript.
loading
Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate.
Phuphuakrat, Angsana; Pasomsub, Ekawat; Chantratita, Wasun; Mahasirimongkol, Surakameth; Disthabanchong, Sinee; Sungkanuparph, Somnuek; Kiertiburanakul, Sasisopin.
Affiliation
  • Phuphuakrat A; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
  • Pasomsub E; Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
  • Chantratita W; Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Mahasirimongkol S; Division of Genomic Medicine and Innovation Support, Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.
  • Disthabanchong S; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
  • Sungkanuparph S; Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
  • Kiertiburanakul S; Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.
J Int Assoc Provid AIDS Care ; 21: 23259582221134751, 2022.
Article in En | MEDLINE | ID: mdl-36314476
Tenofovir disoproxil fumarate (TDF) associates with renal tubular dysfunction (RTD) in some people living with HIV (PLWH). We studied clinical and genetic factors associated with RTD in Thai PLWH receiving TDF. RTD was diagnosed in 13 of 65 (20%) patients. The median (interquartile range) age and CD4 cell counts were 43.8 (40.4-50.9) years and 554 (437-716) cells/mm3, respectively. The median duration of TDF use was 46.9 (31.5-54.1) months. Univariate logistic regression demonstrated body mass index (BMI), concomitant use of protease inhibitor (PI), hyperlipidemia, and homozygous C/C SNP rs1059751 of ABCC4 gene as predisposing factors of RTD. In multivariate model, concomitant use of PI [adjusted odds ratio (aOR) 11.39; 95% confidence interval (CI), 1.59- 81.56; P = 0.015], hyperlipidemia (aOR 8.59; 95% CI, 1.46-50.40; P = 0.017), and BMI (aOR 0.76; 95% CI, 0.59-0.98; P = 0.037) remained associated with RTD in patients receiving TDF. PLWH receiving TDF with the presence of these factors should be closely monitored for RTD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Int Assoc Provid AIDS Care Year: 2022 Document type: Article Affiliation country: Thailand Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Int Assoc Provid AIDS Care Year: 2022 Document type: Article Affiliation country: Thailand Country of publication: United States